Global Nervous System Markers Market Research Report 2023

Nervous System Markers Market

A major percentage of world population is affected by neurological disorders, this in turn is causing major disabilities globally. Due to the high incidence of neurological disorders, there is the need for biomarkers as biomarkers measure biological states and are used for indication of both pathogenic as well as normal biological process in terms of therapeutic intervention. Biomarkers can also be utilized in combination for accessing the state of the disease of an individual.

According to the "Global Use of Medicines 2023" released by the IQVIA Institute, the global drug expenditure in 2022 will be approximately US$1.48 trillion (excluding costs related to COVID vaccines and therapies), and it is predicted that it will grow at a rate of 3%-6% in the next few years. In terms of regional development trends, high-income countries such as Western Europe, North America, and Japan are expected to experience slower growth in the next few years due to already high per capita usage, while growth markets such as Asia, Latin America, and Eastern Europe are expected to grow strongly. In terms of drug expenditure, China's drug expenditure in 2022 will be about 166 billion US dollars. It is expected that the expenditure on medicines will only increase in the next few years: From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines; from the perspective of national strategy, in 2016 , the State Council issued the "Healthy China 2030" Planning Outline, and "Healthy China" has risen to a national strategy; from the perspective of industry policy, it has experienced the uncertainty brought about by the initial stage of medical reform, the implementation of the centralized procurement policy and the expansion of the drug reimbursement catalog The update will gradually achieve a dynamic balance of multiple goals such as promoting innovation, stabilizing supply, and reducing the burden on the masses.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nervous System Markers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Nervous System Markers Market Report

1.1 Product Overview and Scope of Nervous System Markers

1.2 Nervous System Markers Segment by Type

1.2.1 Global Nervous System Markers Market Value Comparison by Type (2023-2029)

1.2.2 Imaging Biomarkers

1.2.3 Metabolomics Biomarkers

1.2.4 Proteomic Biomarkers

1.2.5 Genomics Biomarkers

1.3 Nervous System Markers Segment by Application

1.3.1 Global Nervous System Markers Market Value by Application: (2023-2029)

1.3.2 Spinal Muscular Atrophy (SMA)

1.3.3 Multiple Sclerosis

1.3.4 Depression

1.3.5 Schizophrenia

1.3.6 Huntington's Disease

1.3.7 Parkinson's Disease

1.3.8 Alzheimer's Disease

1.4 Global Nervous System Markers Market Size Estimates and Forecasts

1.4.1 Global Nervous System Markers Revenue 2018-2029

1.4.2 Global Nervous System Markers Sales 2018-2029

1.4.3 Global Nervous System Markers Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Nervous System Markers Sales Market Share by Manufacturers (2018-2023)

2.2 Global Nervous System Markers Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Nervous System Markers Average Price by Manufacturers (2018-2023)

2.4 Global Nervous System Markers Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Nervous System Markers, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Nervous System Markers, Product Type & Application

2.7 Nervous System Markers Market Competitive Situation and Trends

2.7.1 Nervous System Markers Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Nervous System Markers Players Market Share by Revenue

2.7.3 Global Nervous System Markers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Nervous System Markers Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Nervous System Markers Global Nervous System Markers Sales by Region: 2018-2029

3.2.1 Global Nervous System Markers Sales by Region: 2018-2023

3.2.2 Global Nervous System Markers Sales by Region: 2024-2029

3.3 Global Nervous System Markers Global Nervous System Markers Revenue by Region: 2018-2029

3.3.1 Global Nervous System Markers Revenue by Region: 2018-2023

3.3.2 Global Nervous System Markers Revenue by Region: 2024-2029

3.4 North America Nervous System Markers Market Facts & Figures by Country

3.4.1 North America Nervous System Markers Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Nervous System Markers Sales by Country (2018-2029)

3.4.3 North America Nervous System Markers Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Nervous System Markers Market Facts & Figures by Country

3.5.1 Europe Nervous System Markers Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Nervous System Markers Sales by Country (2018-2029)

3.5.3 Europe Nervous System Markers Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Nervous System Markers Market Facts & Figures by Country

3.6.1 Asia Pacific Nervous System Markers Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Nervous System Markers Sales by Country (2018-2029)

3.6.3 Asia Pacific Nervous System Markers Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Nervous System Markers Market Facts & Figures by Country

3.7.1 Latin America Nervous System Markers Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Nervous System Markers Sales by Country (2018-2029)

3.7.3 Latin America Nervous System Markers Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Nervous System Markers Market Facts & Figures by Country

3.8.1 Middle East and Africa Nervous System Markers Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Nervous System Markers Sales by Country (2018-2029)

3.8.3 Middle East and Africa Nervous System Markers Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4.1 Global Nervous System Markers Sales by Type (2018-2029)

4.1.1 Global Nervous System Markers Sales by Type (2018-2023)

4.1.2 Global Nervous System Markers Sales by Type (2024-2029)

4.1.3 Global Nervous System Markers Sales Market Share by Type (2018-2029)

4.2 Global Nervous System Markers Revenue by Type (2018-2029)

4.2.1 Global Nervous System Markers Revenue by Type (2018-2023)

4.2.2 Global Nervous System Markers Revenue by Type (2024-2029)

4.2.3 Global Nervous System Markers Revenue Market Share by Type (2018-2029)

4.3 Global Nervous System Markers Price by Type (2018-2029)

5.1 Global Nervous System Markers Sales by Application (2018-2029)

5.1.1 Global Nervous System Markers Sales by Application (2018-2023)

5.1.2 Global Nervous System Markers Sales by Application (2024-2029)

5.1.3 Global Nervous System Markers Sales Market Share by Application (2018-2029)

5.2 Global Nervous System Markers Revenue by Application (2018-2029)

5.2.1 Global Nervous System Markers Revenue by Application (2018-2023)

5.2.2 Global Nervous System Markers Revenue by Application (2024-2029)

5.2.3 Global Nervous System Markers Revenue Market Share by Application (2018-2029)

5.3 Global Nervous System Markers Price by Application (2018-2029)

6.1 Athena Diagnostics

6.1.1 Athena Diagnostics Corporation Information

6.1.2 Athena Diagnostics Description and Business Overview

6.1.3 Athena Diagnostics Nervous System Markers Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Athena Diagnostics Nervous System Markers Product Portfolio

6.1.5 Athena Diagnostics Recent Developments/Updates

6.2 Myriad RBM

6.2.1 Myriad RBM Corporation Information

6.2.2 Myriad RBM Description and Business Overview

6.2.3 Myriad RBM Nervous System Markers Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Myriad RBM Nervous System Markers Product Portfolio

6.2.5 Myriad RBM Recent Developments/Updates

6.3 QIAGEN

6.3.1 QIAGEN Corporation Information

6.3.2 QIAGEN Description and Business Overview

6.3.3 QIAGEN Nervous System Markers Sales, Revenue and Gross Margin (2018-2023)

6.3.4 QIAGEN Nervous System Markers Product Portfolio

6.3.5 QIAGEN Recent Developments/Updates

6.4 Thermo Fisher Scientific

6.4.1 Thermo Fisher Scientific Corporation Information

6.4.2 Thermo Fisher Scientific Description and Business Overview

6.4.3 Thermo Fisher Scientific Nervous System Markers Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Thermo Fisher Scientific Nervous System Markers Product Portfolio

6.4.5 Thermo Fisher Scientific Recent Developments/Updates

7.1 Nervous System Markers Industry Chain Analysis

7.2 Nervous System Markers Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Nervous System Markers Production Mode & Process

7.4 Nervous System Markers Sales and Marketing

7.4.1 Nervous System Markers Sales Channels

7.4.2 Nervous System Markers Distributors

7.5 Nervous System Markers Customers

8.1 Nervous System Markers Industry Trends

8.2 Nervous System Markers Market Drivers

8.3 Nervous System Markers Market Challenges

8.4 Nervous System Markers Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Nervous System Markers Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Nervous System Markers Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Nervous System Markers Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Nervous System Markers Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Nervous System Markers Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Nervous System Markers Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Nervous System Markers Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Nervous System Markers Average Price (US$/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Nervous System Markers, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Nervous System Markers, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Nervous System Markers, Product Type & Application

    Table 12. Global Key Manufacturers of Nervous System Markers, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Nervous System Markers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nervous System Markers as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Nervous System Markers Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Nervous System Markers Sales by Region (2018-2023) & (K Units)

    Table 18. Global Nervous System Markers Sales Market Share by Region (2018-2023)

    Table 19. Global Nervous System Markers Sales by Region (2024-2029) & (K Units)

    Table 20. Global Nervous System Markers Sales Market Share by Region (2024-2029)

    Table 21. Global Nervous System Markers Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Nervous System Markers Revenue Market Share by Region (2018-2023)

    Table 23. Global Nervous System Markers Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Nervous System Markers Revenue Market Share by Region (2024-2029)

    Table 25. North America Nervous System Markers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Nervous System Markers Sales by Country (2018-2023) & (K Units)

    Table 27. North America Nervous System Markers Sales by Country (2024-2029) & (K Units)

    Table 28. North America Nervous System Markers Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Nervous System Markers Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Nervous System Markers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Nervous System Markers Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Nervous System Markers Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Nervous System Markers Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Nervous System Markers Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Nervous System Markers Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Nervous System Markers Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Nervous System Markers Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Nervous System Markers Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Nervous System Markers Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Nervous System Markers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Nervous System Markers Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Nervous System Markers Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Nervous System Markers Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Nervous System Markers Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Nervous System Markers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Nervous System Markers Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Nervous System Markers Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Nervous System Markers Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Nervous System Markers Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Nervous System Markers Sales (K Units) by Type (2018-2023)

    Table 51. Global Nervous System Markers Sales (K Units) by Type (2024-2029)

    Table 52. Global Nervous System Markers Sales Market Share by Type (2018-2023)

    Table 53. Global Nervous System Markers Sales Market Share by Type (2024-2029)

    Table 54. Global Nervous System Markers Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Nervous System Markers Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Nervous System Markers Revenue Market Share by Type (2018-2023)

    Table 57. Global Nervous System Markers Revenue Market Share by Type (2024-2029)

    Table 58. Global Nervous System Markers Price (US$/Unit) by Type (2018-2023)

    Table 59. Global Nervous System Markers Price (US$/Unit) by Type (2024-2029)

    Table 60. Global Nervous System Markers Sales (K Units) by Application (2018-2023)

    Table 61. Global Nervous System Markers Sales (K Units) by Application (2024-2029)

    Table 62. Global Nervous System Markers Sales Market Share by Application (2018-2023)

    Table 63. Global Nervous System Markers Sales Market Share by Application (2024-2029)

    Table 64. Global Nervous System Markers Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Nervous System Markers Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Nervous System Markers Revenue Market Share by Application (2018-2023)

    Table 67. Global Nervous System Markers Revenue Market Share by Application (2024-2029)

    Table 68. Global Nervous System Markers Price (US$/Unit) by Application (2018-2023)

    Table 69. Global Nervous System Markers Price (US$/Unit) by Application (2024-2029)

    Table 70. Athena Diagnostics Corporation Information

    Table 71. Athena Diagnostics Description and Business Overview

    Table 72. Athena Diagnostics Nervous System Markers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 73. Athena Diagnostics Nervous System Markers Product

    Table 74. Athena Diagnostics Recent Developments/Updates

    Table 75. Myriad RBM Corporation Information

    Table 76. Myriad RBM Description and Business Overview

    Table 77. Myriad RBM Nervous System Markers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 78. Myriad RBM Nervous System Markers Product

    Table 79. Myriad RBM Recent Developments/Updates

    Table 80. QIAGEN Corporation Information

    Table 81. QIAGEN Description and Business Overview

    Table 82. QIAGEN Nervous System Markers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 83. QIAGEN Nervous System Markers Product

    Table 84. QIAGEN Recent Developments/Updates

    Table 85. Thermo Fisher Scientific Corporation Information

    Table 86. Thermo Fisher Scientific Description and Business Overview

    Table 87. Thermo Fisher Scientific Nervous System Markers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 88. Thermo Fisher Scientific Nervous System Markers Product

    Table 89. Thermo Fisher Scientific Recent Developments/Updates

    Table 90. Key Raw Materials Lists

    Table 91. Raw Materials Key Suppliers Lists

    Table 92. Nervous System Markers Distributors List

    Table 93. Nervous System Markers Customers List

    Table 94. Nervous System Markers Market Trends

    Table 95. Nervous System Markers Market Drivers

    Table 96. Nervous System Markers Market Challenges

    Table 97. Nervous System Markers Market Restraints

    Table 98. Research Programs/Design for This Report

    Table 99. Key Data Information from Secondary Sources

    Table 100. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Nervous System Markers

    Figure 2. Global Nervous System Markers Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Nervous System Markers Market Share by Type in 2022 & 2029

    Figure 4. Imaging Biomarkers Product Picture

    Figure 5. Metabolomics Biomarkers Product Picture

    Figure 6. Proteomic Biomarkers Product Picture

    Figure 7. Genomics Biomarkers Product Picture

    Figure 8. Global Nervous System Markers Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global Nervous System Markers Market Share by Application in 2022 & 2029

    Figure 10. Spinal Muscular Atrophy (SMA)

    Figure 11. Multiple Sclerosis

    Figure 12. Depression

    Figure 13. Schizophrenia

    Figure 14. Huntington's Disease

    Figure 15. Parkinson's Disease

    Figure 16. Alzheimer's Disease

    Figure 17. Global Nervous System Markers Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 18. Global Nervous System Markers Market Size (2018-2029) & (US$ Million)

    Figure 19. Global Nervous System Markers Sales (2018-2029) & (K Units)

    Figure 20. Global Nervous System Markers Average Price (US$/Unit) & (2018-2029)

    Figure 21. Nervous System Markers Report Years Considered

    Figure 22. Nervous System Markers Sales Share by Manufacturers in 2022

    Figure 23. Global Nervous System Markers Revenue Share by Manufacturers in 2022

    Figure 24. The Global 5 and 10 Largest Nervous System Markers Players: Market Share by Revenue in 2022

    Figure 25. Nervous System Markers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 26. Global Nervous System Markers Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 27. North America Nervous System Markers Sales Market Share by Country (2018-2029)

    Figure 28. North America Nervous System Markers Revenue Market Share by Country (2018-2029)

    Figure 29. U.S. Nervous System Markers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. Canada Nervous System Markers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Europe Nervous System Markers Sales Market Share by Country (2018-2029)

    Figure 32. Europe Nervous System Markers Revenue Market Share by Country (2018-2029)

    Figure 33. Germany Nervous System Markers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. France Nervous System Markers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. U.K. Nervous System Markers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. Italy Nervous System Markers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. Russia Nervous System Markers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. Asia Pacific Nervous System Markers Sales Market Share by Region (2018-2029)

    Figure 39. Asia Pacific Nervous System Markers Revenue Market Share by Region (2018-2029)

    Figure 40. China Nervous System Markers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Japan Nervous System Markers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. South Korea Nervous System Markers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. India Nervous System Markers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Australia Nervous System Markers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Taiwan Nervous System Markers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Indonesia Nervous System Markers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Thailand Nervous System Markers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Malaysia Nervous System Markers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Philippines Nervous System Markers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. Latin America Nervous System Markers Sales Market Share by Country (2018-2029)

    Figure 51. Latin America Nervous System Markers Revenue Market Share by Country (2018-2029)

    Figure 52. Mexico Nervous System Markers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Brazil Nervous System Markers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. Argentina Nervous System Markers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 55. Middle East & Africa Nervous System Markers Sales Market Share by Country (2018-2029)

    Figure 56. Middle East & Africa Nervous System Markers Revenue Market Share by Country (2018-2029)

    Figure 57. Turkey Nervous System Markers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 58. Saudi Arabia Nervous System Markers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 59. U.A.E Nervous System Markers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 60. Global Sales Market Share of Nervous System Markers by Type (2018-2029)

    Figure 61. Global Revenue Market Share of Nervous System Markers by Type (2018-2029)

    Figure 62. Global Nervous System Markers Price (US$/Unit) by Type (2018-2029)

    Figure 63. Global Sales Market Share of Nervous System Markers by Application (2018-2029)

    Figure 64. Global Revenue Market Share of Nervous System Markers by Application (2018-2029)

    Figure 65. Global Nervous System Markers Price (US$/Unit) by Application (2018-2029)

    Figure 66. Nervous System Markers Value Chain

    Figure 67. Nervous System Markers Production Process

    Figure 68. Channels of Distribution (Direct Vs Distribution)

    Figure 69. Distributors Profiles

    Figure 70. Bottom-up and Top-down Approaches for This Report

    Figure 71. Data Triangulation

    Figure 72. Key Executives Interviewed